This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Basaria, S. Articles by Dobs, A. S. Search for Related Content PubMed PubMed Citation Articles by Basaria, S. Articles by Dobs, A. S. Related Collections Risk Factors Epidemiology

(Circulation. 2007;116:2658-2661.)
© 2007 American Heart Association, Inc.

Editorial

Testosterone Making an Entry Into the Cardiometabolic World

Shehzad Basaria, MD; Adrian S. Dobs, MD, MHS

From the Division of Endocrinology & Metabolism, The Johns Hopkins University School of Medicine, Baltimore, Md.

Correspondence to Adrian S. Dobs, MD, MHS, Division of Endocrinology & Metabolism, Johns Hopkins University School of Medicine, 1830 E Monument St, Suite 328, Baltimore, MD 21287. E-mail adobs@jhu.edu

Key Words: Editorials • epidemiology • hormones • men • testosterone

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Testosterone, the predominant sex hormone in men, is produced by the testes under stimulation by the gonadotrophs in the pituitary, which in turn are controlled by gonadotropin-releasing hormone neurons in the hypothalamus. A young adult man generally produces 3 to 10 mg of testosterone daily, which translates into serum values of 300 to 1000 ng/dL. The consequences of classical male hypogonadism (primary or secondary) have been long known to physicians and patients alike and include decreased libido, erectile dysfunction, osteoporosis, reduced sexual hair, and changes in body habitus. Recently, we have come to appreciate that reductions in serum testosterone resulting from aging or chronic disease have signs and symptoms similar to those seen in classical male hypogonadism, along with increased fat mass, decreased lean body mass, decreased muscle strength, and diminished quality of life.¹ During the past decade, reports have been trickling in, mainly from laboratory and epidemiological studies (and a few clinical studies), linking differences in serum testosterone levels to various cardiovascular risk factors and also directly to cardiovascular disease and death. The article by Khaw et al² in this issue of Circulation is another link to this growing chain.

Article p 2694

Thirteen years ago, Phillips et al³ reported that low total and free testosterone levels were inversely linked to coronary artery disease, even after adjusting for age and adiposity. This observation still holds true, as was recently supported by a study showing that men with angiographically proven coronary artery disease had lower levels of testosterone than those . . . [Full Text of this Article]

This article has been cited by other articles:

				A. M. Traish, F. Saad, R. J. Feeley, and A. Guay The Dark Side of Testosterone Deficiency: III. Cardiovascular Disease J Androl, September 1, 2009; 30(5): 477 - 494. [Abstract] [Full Text] [PDF]

				A. Tivesten, L. Vandenput, F. Labrie, M. K. Karlsson, O. Ljunggren, D. Mellstrom, and C. Ohlsson Low Serum Testosterone and Estradiol Predict Mortality in Elderly Men J. Clin. Endocrinol. Metab., July 1, 2009; 94(7): 2482 - 2488. [Abstract] [Full Text] [PDF]

				J. J. Carrero, A. R. Qureshi, P. Parini, S. Arver, B. Lindholm, P. Barany, O. Heimburger, and P. Stenvinkel Low Serum Testosterone Increases Mortality Risk among Male Dialysis Patients J. Am. Soc. Nephrol., March 1, 2009; 20(3): 613 - 620. [Abstract] [Full Text] [PDF]

				G. Jackson CHAPTER 15c Erectile Dysfunction ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text]